Cell division in large embryos is coordinated by spatial waves of Cyclin B–Cdk1 activity that spread through the cytoplasm and affect cortical contractility. However, ...
GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its ...
An origami scaffold uses electrical repair cues and light-triggered heating to promote cartilage formation while limiting ...
Phase 3 manufacturing campaign on track for completion no later than third quarter 2026, supporting expected pivotal trial in advanced ...
Researchers at the University of the Sunshine Coast have discovered a natural compound derived from Australian bees for ...
Turmeric and magnesium are two popular dietary supplements with similar health benefits – but they act differently in the ...
Morning Overview on MSN
RNA-based therapy reaches proof-of-concept for autism-related gene mutations in preclinical models
A single injection into the bloodstream of a mouse corrected a mutation linked to autism in neurons throughout the brain and ...
This article was produced by Earth | Food | Life, a project of the Independent Media Institute. It is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License ...
Morning Overview on MSN
Gut bacteria may trigger ALS by producing toxic sugars that spark an immune attack on the brain
Amyotrophic lateral sclerosis has long been treated as a disease of the brain and spinal cord. A study published in May 2026 ...
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today ...
NKTR looks de-risked after positive Rezpeg phase 2 data in atopic dermatitis & alopecia areata, with 80% upside and $1.1B ...
NXP900 Phase 1b clinical program continues to enroll patients at select sites in the USNXP900 preclinical presentations at the 2026 American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results